Suggestions
Idioma
Anais Brasileiros de Dermatologia
Anais Brasileiros de Dermatologia
ISSN: 0365-0596

Anais Brasileiros de Dermatologia is the official scientific publication of the Brazilian Society of Dermatology (SBD - Sociedade Brasileira de Dermatologia). The journal has been published since 1925.

It is a bimonthly open access peer-reviewed journal devoted to the dissemination of studies, evidence and technical-scientific reports that are original and unpublished, results from research, reviews or communications about dermatology and related fields.

The journal is focused on Tropical Dermatology, Parasitic and Infectious Dermatology, STDs/AIDS and Dermopathology.

The opinions and statements contained in the journal are the sole and exclusive responsibility of their authors, and do not necessarily coincide with those of the Editorial Staff, the Advisory Board or the Brazilian Society of Dermatology.

See more
Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more
Follow us
X
Contact
Subscribe
Alert
Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more
Impact factor 2025
4.4
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2025
2.9
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2025
0.595
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2025
1.196
Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more
Time to first decision
13 days
View more metrics
Hide
Last published articles
Randomized, double-blind pilot study on botulinum toxin type A in the treatment of axillary hidradenitis suppurativa
Jessica Shen Tsy Wu Kim, Kevin Yun Kim, Laís de Abreu Mutti, Fernanda de Carvalho Tironi, Anamaria da Silva Facina, Samira Yarak, Sergio Henrique Hirata
An Bras Dermatol. 2026;101: 501461
Full text access
A comparative clinical and sociodemographic analysis of well-differentiated squamous cell carcinoma and keratoacanthoma in kidney transplant recipients and immunocompetent individuals
Camila Santos Lopes, Lara Araújo Dias, Sergio Henrique Hirata, Milvia Maria Simões e Silva Enokihara, Heron Fernando de Sousa Gonzaga, Jane Tomimori
An Bras Dermatol. 2026;101: 501452
Full text access
Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis
Yusuf Demir, Hande Ogun, Bercemhan Sulu, Muazzez Cigdem Oba, Emire Seyahi
An Bras Dermatol. 2026;101: 501443
Full text access
Comment on “Risk factors associated with chronic cutaneous graft-versus-host disease following hematopoietic stem cell transplantation: a pediatric cohort” – Reply
Daniela Carvajal, Teresa Dossi, Camila Downey, Daniela Krämer, Natalia González, Javier Fernández, Paula Muñoz
An Bras Dermatol. 2026;101: 501459
Full text access
Latest issue
Issue
Cover Vol. 101. Issue 5. (In progress) Vol. 101. Issue 5. (In progress)
(September - October 2026)
This issue is in progress but contains articles that are final and fully citable.
Editorial
The new metrics of Anais Brasileiros de Dermatologia
Hiram Larangeira de Almeida, Jane Tomimori, Neusa Yuriko Sakai Valente, Renata Ferreira Magalhães
An Bras Dermatol. 2026;101: 501447
Full text access
Original article
From depigmentation to dysmetabolism: epicardial fat thickness and atherogenic lipid ındices in vitiligo
Mustafa Esen, Abdullah Demirbas, Esin Diremsizoglu, Murat Harman, Kamran İldırımlı
An Bras Dermatol. 2026;101: 501428
Full text access
Histopathological analysis of CD163 and myeloperoxidase expression in neutrophil-rich dermatoses
Danielle Carvalho Quintella, Cristiane Bedran Milito, Tullia Cuzzi
An Bras Dermatol. 2026;101: 501425
Full text access
Omalizumab-based therapy in normocomplementemic urticarial vasculitis: a retrospective case series of 18 patients
Melek Aslan Kayiran, Kubra Akdemir Yucel, Bengu Cobanoglu Simsek, Mehmet Salih Gurel
An Bras Dermatol. 2026;101: 501424
Full text access
View latest issue View all issues
Editorial Board
Hiram Larangeira de Almeida Jr
Hiram Larangeira de Almeida Jr
Universidade Federal de Pelotas, Pelotas, Brazil
View editorial board
All issues
portada-Vol. 101. Issue 5. (In progress)
September - October
Volume 101 . Issue. 5
In progress
portada-Vol. 101. Issue 4.
July - August
Volume 101 . Issue. 4
portada-Vol. 101. Issue 3.
May - June
Volume 101 . Issue. 3
portada-Vol. 101. Issue 2.
March - April
Volume 101 . Issue. 2
View all issues
Supplements
portada-Vol. 95. Issue  S1.
November - December
Volume 95. Issue. S1
Pages 1-82
View all supplements
Instructions for authors
Most often read
Continuing Medical Education
Taciana Dal'Forno-Dini, Martina Souilljee Birck, Rafaela Malmann Saalfeld, Clayton Luiz Dornelles Macedo, Edileia Bagatin
10.1016/j.abd.2025.501270
An Bras Dermatol. 2026;101:
This article has been read 11.015 times
View all Most Often read articles
Idiomas
Anais Brasileiros de Dermatologia